Grand National horse died from ‘infection and sepsis'
The 13-year-old horse developed a 'severe bacterial respiratory infection' that resulted in the onset of sepsis as the horse's immune system was 'severely compromised' after running on Saturday.
Post-mortem examinations concluded that an 'exercise-associated episode' which led the 13-year-old to collapse was no longer a factor by the time of his death on Tuesday.
The horse – who collapsed after jumping the last in Saturday's showpiece – died of complications linked to pleuropneumonia (a lung infection), although blood tests taken on the day of the race showed no presence of the virus. Vets believe it is not possible to separate the emergence of the secondary problem from his run at Aintree.
A statement from the BHA said: 'The findings of the post-mortem state that the exercise-associated episode experienced by the horse after the race had concluded by the time of death.
'However, a severe bacterial respiratory infection [pleuropneumonia] had occurred post-race which led to the horse's deterioration on Monday evening, with the subsequent onset of sepsis or endotoxaemia [the release of harmful substances into the bloodstream from bacteria] likely to have been a key factor in the cause of death.
'Blood tests taken from the day of the race indicate that the infection had not been present in the horse on raceday, and was therefore developed after the race.'
After initially showing signs of recovery, Celebre D'Allen's condition 'deteriorated significantly' and he died on Tuesday.
Micheal Nolan, Celebre D'Allen's rider, was handed a 10-day suspension after Aintree stewards ruled he had 'continued in the race when the horse appeared to have no more to give and was clearly losing ground after the second-last fence'.
But the post-mortem examination found that the effects of the incident had 'concluded by the time of death'.
The infection resulted in the onset of sepsis, which is 'likely to have been a key factor' in the cause of death.
Blood tests taken on the day of the race indicated that the infection had not been present in the horse on raceday.
The BHA said the post-mortem was just 'one part' of their reviewing process of any fatality. Celebre D'Allen was a 125-1 shot at the National won by jockey Patrick Mullins on Nick Rockett.
This is great to see 🙌
Broadway Boy and Celebre D'Allen who ran in yesterday's Randox Grand National are heading off home after being given the time and treatment they needed from our expert teams. pic.twitter.com/RGsqKRwMtz
— Aintree Racecourse (@AintreeRaces) April 6, 2025
Celebre D'Allen's death prompted criticism from animal-rights activists, with Animal Rising and Animal Aid attacking the sport for allowing him to run aged 13.
The BHA said there had been 24 13-year-old horses since 2000 who have competed in the Grand National, with no previous fatalities.
There was also concern at the Grand National for Broadway Boy, who suffered a heavy fall at the 25th fence while leading the race.
Vets and staff rushed to the scene and it was confirmed on Sunday that, although the horse was 'stiff and sore', it was 'travelling home' safely.
National-winning jockey suspended
Winning jockey Mullins was also banned this week after being handed an eight-day suspension for overuse of the whip on the run to the finish line.
Mullins, who led home a one-two-three for father and trainer Willie Mullins, was found to have used the whip eight times after the last fence, one more than the permitted seven in jumps racing.
His ride was referred to the Whip Review Committee who elected to sanction the amateur jockey for breaching the limit, and he will be suspended for eight separate days including April 23 and 25.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 days ago
- The Independent
A single injection for newborns could protect them against HIV for years, study suggests
A single injection at birth could shield children from HIV for years, a study has suggested. The study is one of the first to show that the first weeks of life offer a critical window where the immune system is naturally more tolerant, meaning it is the optimal time to deliver gene therapies that would otherwise be rejected at older ages. Researchers hope the gene therapy jab could be used in the future to fight against paediatric infections in high-risk areas. 'Nearly 300 children are infected with HIV each day,' said first author Amir Ardeshir, associate professor of microbiology and immunology at the Tulane National Primate Research Center in the US. 'This approach could help protect newborns in high-risk areas during the most vulnerable period of their lives.' The study, published in the journal Nature, created a gene therapy that programs cells to produce HIV-fighting antibodies. An animal study that tested the injection on non-human primates found it protected them from infection for at least three years without the need for a booster shot. But this was only if the injection was administered in the first month of life. In comparison, those that received the gene therapy between eight and 12 weeks after birth did not tolerate the treatment, study authors explain. 'This is a one-and-done treatment that fits the critical time when these mothers with HIV in resource-limited areas are most likely to see a doctor,' Dr Ardeshir said. 'As long as the treatment is delivered close to birth, the baby's immune system will accept it and believe it's part of itself.' Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health Organization (WHO). But if they do not receive medication, the rate of transmission of HIV from the mother to her child either during pregnancy, labour, delivery or breastfeeding ranges between 15 per cent and 45 per cent, according to WHO data. Although antiviral treatments can suppress the virus and limit transmission, adherence to treatment and doctor visits decline after childbirth, particularly in areas with limited access to healthcare, the study authors noted. This gene therapy uses a harmless virus that can deliver genetic code to cells, but is different to a vaccine. This virus was injected into muscle cells and delivered instructions to produce antibodies that are capable of neutralising multiple strains of HIV. Researchers explained that previous studies have found repeated infusions of the injection are needed for it to work. But by injecting it into muscle cells, researchers say they become 'micro-factories that just keep producing these antibodies'. Newborns showed greater tolerance to the jab, which prevented infection during breastfeeding. However, older infants and juveniles were more likely to have produced anti-drug antibodies that shut down the treatment. In addition, exposing a foetus to the antibodies from the gene therapy before birth helps older infants accept the therapy. However, because it has only been tested on animals, researchers still do not know if it will work on human children. If successful, this treatment could dramatically reduce mother-to-child HIV transmission rates in high-risk regions such as sub-Saharan Africa, where 90 per cent of paediatric HIV cases can be found. 'Nothing like this was possible to achieve even 10 years ago,' Dr Ardeshir said. 'This was a huge result, and now we have all the ingredients to take on HIV.'
The National
5 days ago
- The National
'He was just bones': Gaza volunteer reveals starvation horrors
Ibrahim Shareef Al-Ashi, 29, worked as a dentist before the genocide and for the last year has been volunteering to help feed others at the Gaza Soup Kitchen. He told the Sunday National that people were reduced to eating just one meal a day as Israel prevents food from entering Palestine. Al-Ashi said: 'If you eat three meals today, you will not eat tomorrow.' He added that before the famine, the Gaza Soup Kitchen would deliver around 2000 meals a day – this is now down to just 50 as the markets are now 'completely empty'. Al-Ashi worked as a dentist before the genocide began (Image: Supplied) What little there is has become inordinately expensive due to scarcity, he said, with the price of a kilogram of flour rocketing from less than $1 to $30. Children come to the soup kitchen suffering from acute malnutrition, said Al-Ashi, who told the story of seeing one boy who 'came to our clinic as a skeleton, he was just bones, there is no muscle in his body'. So violent are the effects of malnutrition that the boy was given food supplements. [[Gaza]] was on the brink of running out of food supplements on Friday, according to the United Nations, with supplies of Ready-to-Use Therapeutic Food (RUTF) expected to run out by mid-August if the situation did not change. RUTF is an energy-dense paste which comes in a foil sachet and is used to treat children with severe wasting, according to Unicef's website. It is made with peanuts, sugar, milk powder, oil, vitamins and minerals and does not require cooking or preparation involving water, meaning it does not carry the risk of contamination. Unicef has previously warned that due to overlapping crises throughout the world, its price has spiked. Palestinians are currently subsisting on a diet of rice, lentils or bread, but there is no meat, said Al-Ashi. He lives in Gaza City, with his mother, brother and sister, having returned to his home after a period of displacement in the south. Though the engineered famine in Gaza has sparked international condemnation of Israel and appears to have spurred some into symbolic gestures like France's commitment to recognise Palestine in September, Israel's military assault on the territory remains relentless. 'Every day there are airstrikes, if you can hear the drone, it is like a buzzy sound, for us every day, every hour, it is a fact of life to hear it,' said Al-Ashi. 'The airstrikes never stop and there is no safe place here in Gaza.' He added: 'We are not numbers, we are mothers, children and families. People here are dying from hunger because of the world's silence. 'We are living in catastrophe.' While starvation can be treated, its long-term effects can be devastating. Sufferers can experience impaired fertility, heart attacks, kidney failure, stunted growth and fragile bones. Mental health, already under intense strain amid displacement and widespread death, can be put under extra pressure from malnutrition, with sufferers experiencing anxiety, depression and poor sleep. Unicef said previously that from April to mid-July, 20,504 children had been admitted with acute malnutrition, of which 3247 were suffering from severe acute malnutrition, nearly triple the number in the first three months of the year. A friend of Ibrahim Shareef Al-Ashi's from Italy has set up a fundraiser to support him. You can find out more and donate by clicking here. –
Telegraph
6 days ago
- Telegraph
This killer of men can no longer be ignored
In medical circles, prostate cancer is often known as 'the invisible killer'. Its early symptoms are hard to detect and it may remain undiagnosed until too late. Some 10,000 men a year are diagnosed with prostate cancer only after at least three visits to their GP. And every year, some 12,000 lives are cut short unnecessarily by the failure to treat this hidden menace before it has spread beyond the prostate gland. So The Telegraph is proud to announce a new campaign calling for a targeted National Health Service screening programme for prostate cancer. It is nothing short of a scandal that such a programme does not already exist. We ardently hope that you, our readers, will join us in a mission to right this wrong and thereby save, over time, many thousands of lives. The importance of early detection and diagnosis has been demonstrated by the huge improvement in survival rates for breast cancer since mass screening for women aged 50-70 was introduced by the NHS in 1988. Since then, it has reduced deaths from breast cancer by at least 20 per cent. The NHS is now extending breast screening to women in their 40s and 70s. Yet there is still no equivalent mass programme for prostate cancer, which is the most common form of cancer for men and the second biggest killer. Middle-aged men are notoriously reluctant to visit the doctor. Prostate cancer presents a particular problem, because patients are embarrassed and may have unjustified fears that a medical examination would be unpleasant. A mass screening programme would help to remove the myths and stigma. The reality is that PSA blood tests — which are simple, cheap and painless — should be routinely offered to patients who are at risk of prostate cancer, especially if they have a family history of the disease. Yet in reality many GPs seem reluctant to do so: more than 5 per cent of prostate sufferers had to make five surgery visits before being offered a PSA test. The answer to this injustice is to roll out a national screening programme, as Prostate Cancer Research and many experts have long advocated. Wes Streeting, the Health Secretary, has lent his support to the Telegraph campaign, but the decision lies with the UK National Screening Committee. We can only hope that its members recognise the overwhelming body of evidence in favour of screening for prostate cancer. The Telegraph will play its part in making sure that the invisible killer can no longer be ignored.
